The pharmaceutical industry will undergo significant changes this summer. A set of standards for the identification of medicinal products (IDMP) from the European Medicines Agency (EMA) will take effect in July, requiring the whole industry to apply the terminologies released by EMA. The changes have raised many concerns regarding how